Cargando…

The Novel Toll-Like Receptor 2 Agonist SUP3 Enhances Antigen Presentation and T Cell Activation by Dendritic Cells

Dendritic cells (DCs) are highly specialized antigen-presenting cells that play crucial roles in innate and adaptive immunity. Previous studies suggested that Toll-like receptor (TLR) agonists could be used as potential adjuvants, as activation of TLRs can boost DC-induced immune responses. TLR2 ago...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Xueheng, Wu, Ning, Shang, Yingli, Liu, Xin, Wu, Tao, Zhou, Yifan, Huang, Jiaoyan, Liao, Xuebin, Wu, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318439/ https://www.ncbi.nlm.nih.gov/pubmed/28270814 http://dx.doi.org/10.3389/fimmu.2017.00158

Ejemplares similares

MicroRNA-21: A Positive Regulator for Optimal Production of Type I and Type III Interferon by Plasmacytoid Dendritic Cells
por: Liu, Fang, et al.
Publicado: (2017)

Delivery of antigen to porcine dendritic cells by fusing antigen with porcine dendritic cells targeting peptide
por: Xia, Tian, et al.
Publicado: (2022)

Self-Antigen Presentation by Dendritic Cells in Autoimmunity
por: Hopp, Ann-Katrin, et al.
Publicado: (2014)

Toll-Like Receptor Ligand Based Adjuvant, PorB, Increases Antigen Deposition on Germinal Center Follicular Dendritic Cells While Enhancing the Follicular Dendritic Cells Network
por: Lisk, Christina, et al.
Publicado: (2020)

Dendritic cells enhance the antigen sensitivity of T cells
por: Garbi, Natalio, et al.
Publicado: (2012)

Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells
por: He, Mi, et al.
Publicado: (2022)

Cross-Presentation of Cell-Associated Antigens by Mouse Splenic Dendritic Cell Populations
por: Thacker, Robert I., et al.
Publicado: (2012)

Toll-Like Receptor 3 Signal in Dendritic Cells Benefits Cancer Immunotherapy
por: Matsumoto, Misako, et al.
Publicado: (2017)

Myocarditis Elicits Dendritic Cell and Monocyte Infiltration in the Heart and Self-Antigen Presentation by Conventional Type 2 Dendritic Cells
por: Van der Borght, Katrien, et al.
Publicado: (2018)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
por: Kirtland, Max E., et al.
Publicado: (2020)

Cross-presentation of antigens by dendritic cells: role of autophagy
por: Das, Mrinmoy, et al.
Publicado: (2015)

Cross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell Subsets
por: Gutiérrez-Martínez, Enric, et al.
Publicado: (2015)

Dysregulated Responsiveness of Circulating Dendritic Cells to Toll-Like Receptors in ANCA-Associated Vasculitis
por: Braudeau, Cécile, et al.
Publicado: (2017)

Delivery of Antigen to CD8(+) Dendritic Cells by Fusing Antigen With Formyl Peptide Receptor-Like 1 Inhibitor Protein Induces Antitumor Immunity
por: Chiang, Chen-Yi, et al.
Publicado: (2019)

A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population
por: Wu, Chiao-Chieh, et al.
Publicado: (2016)

Antigen presentation kinetics control T cell/dendritic cell interactions and follicular helper T cell generation in vivo
por: Benson, Robert A, et al.
Publicado: (2015)

Human dendritic cell targeting peptide can be targeted to porcine dendritic cells to improve antigen capture efficiency to stimulate stronger immune response
por: Xia, Tian, et al.
Publicado: (2022)

Natural toll-like receptor agonists in prophylactic vaccines for dendritic cell activation
por: Peng, Paul, et al.
Publicado: (2015)

The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies
por: Martinsen, Janne Tegder, et al.
Publicado: (2020)

Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists
por: Macedo, Amanda B., et al.
Publicado: (2019)

Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
por: Chakraborty, Samik, et al.
Publicado: (2023)

Disease-Associated Plasmacytoid Dendritic Cells
por: Li, Shuang, et al.
Publicado: (2017)

Toll-like receptors 7 and 9 regulate the proliferation and differentiation of B cells in systemic lupus erythematosus
por: Wen, Luyao, et al.
Publicado: (2023)

Dendritic cell-based vaccine prepared with recombinant Lactococcus lactis enhances antigen cross-presentation and antitumor efficacy through ROS production
por: Zhang, Tingting, et al.
Publicado: (2023)

Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy
por: Peng, Xin, et al.
Publicado: (2021)

Dendritic Cell Vaccines in Ovarian Cancer
por: Zhang, Xi, et al.
Publicado: (2021)

Editorial: Novel Platform for Antigen Delivery to Dendritic Cells for Immunotherapy
por: Plantinga, Maud, et al.
Publicado: (2022)

Toll-Like Receptor 4 on both Myeloid Cells and Dendritic Cells Is Required for Systemic Inflammation and Organ Damage after Hemorrhagic Shock with Tissue Trauma in Mice
por: Zettel, Kent, et al.
Publicado: (2017)

Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells
por: Montealegre, Sebastian, et al.
Publicado: (2019)

Metabolic Regulation of Dendritic Cell Differentiation
por: He, Zhimin, et al.
Publicado: (2019)

Activation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100
por: Naumann, Kai, et al.
Publicado: (2013)

Dendritic Cells in the Periphery Control Antigen-Specific Natural and Induced Regulatory T Cells
por: Yamazaki, Sayuri, et al.
Publicado: (2013)

Incorporation of Toll-Like Receptor Ligands and Inflammasome Stimuli in GM3 Liposomes to Induce Dendritic Cell Maturation and T Cell Responses
por: Nijen Twilhaar, Maarten K., et al.
Publicado: (2022)

Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity
por: Chiang, Chen-Yi, et al.
Publicado: (2018)

Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection
por: Du, Yanqin, et al.
Publicado: (2022)

Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells
por: Shen, Kuan-Yin, et al.
Publicado: (2020)

Toll-like Receptors and Inflammatory Bowel Disease
por: Lu, Yue, et al.
Publicado: (2018)

Chlamydia trachomatis Infection Impairs MHC-I Intracellular Trafficking and Antigen Cross-Presentation by Dendritic Cells
por: Del Balzo, Diego, et al.
Publicado: (2021)

C-Reactive Protein Suppresses the Th17 Response Indirectly by Attenuating the Antigen Presentation Ability of Monocyte Derived Dendritic Cells in Experimental Autoimmune Encephalomyelitis
por: Shen, Zhi-Yuan, et al.
Publicado: (2021)

The Superior Ability of Human BDCA3(+) (CD141(+)) Dendritic Cells (DCs) to Cross-Present Antigens Derived From Necrotic Lung Cancer Cells
por: Gu, Fei-fei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c7i484q6nd6bl4g3g1u2o9esaa